SNOA News & Events

Sonoma Pharmaceuticals announced the pricing of its public offering made on a firm commitment basis with gross proceeds to the Company expected to be approximately $4M, before deducting fees and other expenses payable by the Company. The offering consists of 2,962,963 shares of common stock and 2,962,963 warrants. Each share of common stock is being sold at a purchase price of $1.35 per share. The warrants have an exercise price of $1.35 per share. In addition, Sonoma has granted Dawson James Securities a 45-day option to purchase up to 15% of the number of shares or warrants sold in the offering solely to cover over-allotments, if any. The offering is expected to close on April 27, subject to the satisfaction of customary closing conditions. Dawson James Securities is acting as sole bookrunner for the offering.

Sonoma Pharmaceuticals announced the U.S. retail launch of its advanced HOCl-based burn relief hydrogel in CVS (CVS) and Walmart (WMT) stores nationwide. The hydrogel is indicated for the management of minor burns and skin irritations. This launch represents Sonoma's first large-scale consumer-focused burn relief product, building on the Company's established presence in professional healthcare settings, where its HOCl-based solutions have long been used in advanced wound and burn care protocols. Sonoma previously demonstrated its ability to translate clinically proven technologies into scalable consumer offerings through the launch of its diaper rash hydrogel in mass retail in 2025.

Sonoma Pharmaceuticals announced the launch of Aquanil AD, a hypochlorous acid based dermatology product line for sensitive skin, developed exclusively for Persundefinedn & Covey, Inc. for distribution through its established over-the-counter dermatology channels in the U.S. The Aquanil AD product line includes Aquanil AD Repair Mist, a soothing spray for irritated or damaged skin; Aquanil AD Recovery Gel, designed to help reduce the appearance of scars; and Aquanil AD Rescue Serum for relief from rashes, itching and irritation. Each product was specifically designed for sensitive or reactive skin.